David Poulsen
Corporate Officer/Principal chez The University of Montana
Profil
David Poulsen is a Research Associate Professor at The University of Montana.
He was previously the Chief Scientific Officer at Sinapis Pharma, Inc. Poulsen received his undergraduate degree from Brigham Young University and his graduate and doctorate degrees from the University of Delaware.
Postes actifs de David Poulsen
| Sociétés | Poste | Début |
|---|---|---|
| The University of Montana | Corporate Officer/Principal | - |
Anciens postes connus de David Poulsen
| Sociétés | Poste | Fin |
|---|---|---|
Sinapis Pharma, Inc.
 Sinapis Pharma, Inc. BiotechnologyHealth Technology Sinapis Pharma, Inc. provides biotechnology services. It develops methamphetamine, a low-dose intravenous infusion. The company was founded by Howard C. Chandler and Peter Von Doersten in 2009 and is headquartered in Jacksonville, FL. | Directeur Technique/Scientifique/R&D | - |
Formation de David Poulsen
| Brigham Young University | Undergraduate Degree |
| University of Delaware | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Sinapis Pharma, Inc.
Sinapis Pharma, Inc. BiotechnologyHealth Technology Sinapis Pharma, Inc. provides biotechnology services. It develops methamphetamine, a low-dose intravenous infusion. The company was founded by Howard C. Chandler and Peter Von Doersten in 2009 and is headquartered in Jacksonville, FL. | Health Technology |
